A novel approach to enhancing cellular glutathione levels.

Standard

A novel approach to enhancing cellular glutathione levels. / Maher, Pamela; Lewerenz, Jan; Lozano, Carles; Torres, Josep Lluís.

In: J NEUROCHEM, Vol. 107, No. 3, 3, 2008, p. 690-700.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Maher, P, Lewerenz, J, Lozano, C & Torres, JL 2008, 'A novel approach to enhancing cellular glutathione levels.', J NEUROCHEM, vol. 107, no. 3, 3, pp. 690-700. <http://www.ncbi.nlm.nih.gov/pubmed/18702664?dopt=Citation>

APA

Maher, P., Lewerenz, J., Lozano, C., & Torres, J. L. (2008). A novel approach to enhancing cellular glutathione levels. J NEUROCHEM, 107(3), 690-700. [3]. http://www.ncbi.nlm.nih.gov/pubmed/18702664?dopt=Citation

Vancouver

Maher P, Lewerenz J, Lozano C, Torres JL. A novel approach to enhancing cellular glutathione levels. J NEUROCHEM. 2008;107(3):690-700. 3.

Bibtex

@article{f18c98cb527f442b88242c1d2d2f1c2b,
title = "A novel approach to enhancing cellular glutathione levels.",
abstract = "GSH and GSH-associated metabolism provide the major line of defense for the protection of cells from oxidative and other forms of toxic stress. Of the three amino acids that comprise GSH, cysteine is limiting for GSH synthesis. As extracellularly cysteine is readily oxidized to form cystine, cystine transport mechanisms are essential to provide cells with cysteine. Cystine uptake is mediated by system x(c)(-), a Na(+)-independent cystine/glutamate antiporter. Inhibition of system x(c)(-) by millimolar concentrations of glutamate, a pathway termed oxidative glutamate toxicity, results in GSH depletion and nerve cell death. Recently, we described a series of compounds derived from the conjugation of epicatechin (EC) with cysteine and cysteine derivatives that protected nerve cells in culture from oxidative glutamate toxicity by maintaining GSH levels. In this study, we characterize an additional EC conjugate, cysteamine-EC, that is 5- to 10-fold more potent than the earlier conjugates. In addition, we show that these EC conjugates maintain GSH levels by enhancing the uptake of cystine into cells through induction of a disulfide exchange reaction, thereby uncoupling the uptake from system x(c)(-). Thus, these novel EC conjugates have the potential to enhance GSH synthesis under a wide variety of forms of toxic stress.",
author = "Pamela Maher and Jan Lewerenz and Carles Lozano and Torres, {Josep Llu{\'i}s}",
year = "2008",
language = "Deutsch",
volume = "107",
pages = "690--700",
journal = "J NEUROCHEM",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - A novel approach to enhancing cellular glutathione levels.

AU - Maher, Pamela

AU - Lewerenz, Jan

AU - Lozano, Carles

AU - Torres, Josep Lluís

PY - 2008

Y1 - 2008

N2 - GSH and GSH-associated metabolism provide the major line of defense for the protection of cells from oxidative and other forms of toxic stress. Of the three amino acids that comprise GSH, cysteine is limiting for GSH synthesis. As extracellularly cysteine is readily oxidized to form cystine, cystine transport mechanisms are essential to provide cells with cysteine. Cystine uptake is mediated by system x(c)(-), a Na(+)-independent cystine/glutamate antiporter. Inhibition of system x(c)(-) by millimolar concentrations of glutamate, a pathway termed oxidative glutamate toxicity, results in GSH depletion and nerve cell death. Recently, we described a series of compounds derived from the conjugation of epicatechin (EC) with cysteine and cysteine derivatives that protected nerve cells in culture from oxidative glutamate toxicity by maintaining GSH levels. In this study, we characterize an additional EC conjugate, cysteamine-EC, that is 5- to 10-fold more potent than the earlier conjugates. In addition, we show that these EC conjugates maintain GSH levels by enhancing the uptake of cystine into cells through induction of a disulfide exchange reaction, thereby uncoupling the uptake from system x(c)(-). Thus, these novel EC conjugates have the potential to enhance GSH synthesis under a wide variety of forms of toxic stress.

AB - GSH and GSH-associated metabolism provide the major line of defense for the protection of cells from oxidative and other forms of toxic stress. Of the three amino acids that comprise GSH, cysteine is limiting for GSH synthesis. As extracellularly cysteine is readily oxidized to form cystine, cystine transport mechanisms are essential to provide cells with cysteine. Cystine uptake is mediated by system x(c)(-), a Na(+)-independent cystine/glutamate antiporter. Inhibition of system x(c)(-) by millimolar concentrations of glutamate, a pathway termed oxidative glutamate toxicity, results in GSH depletion and nerve cell death. Recently, we described a series of compounds derived from the conjugation of epicatechin (EC) with cysteine and cysteine derivatives that protected nerve cells in culture from oxidative glutamate toxicity by maintaining GSH levels. In this study, we characterize an additional EC conjugate, cysteamine-EC, that is 5- to 10-fold more potent than the earlier conjugates. In addition, we show that these EC conjugates maintain GSH levels by enhancing the uptake of cystine into cells through induction of a disulfide exchange reaction, thereby uncoupling the uptake from system x(c)(-). Thus, these novel EC conjugates have the potential to enhance GSH synthesis under a wide variety of forms of toxic stress.

M3 - SCORING: Zeitschriftenaufsatz

VL - 107

SP - 690

EP - 700

JO - J NEUROCHEM

JF - J NEUROCHEM

SN - 0022-3042

IS - 3

M1 - 3

ER -